Komori
Pharmarise Holdings (2796) · InitiativeDisposal of Treasury Shares

Containing Dilution and Flexible Capital Policy Through Share Repurchases

First written in FY2020-Q1. 8 of 13 entries say "Advanced", first in FY2020-Q2. Latest entry: FY2026.

13entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2020-Q2 – FY2021-Q2AdvancedFY2021 – FY2024OtherFY2025 – FY20262019: 12020: 220202021: 320212022: 220222023: 020232024: 220242025: 120252026: 22026
Same theme, other companies
Flexible Shareholder Returns and Capital Policy Through Board AuthorityA theme 401 companies write about · 0 as a headwind · 402 as a tailwind

18 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 199 companies compared. The sentences above are computed from all 199.Comparing 200 of the theme's 402 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026Disposal of Treasury SharesAnnual report

    「Other (disposal of treasury shares as restricted stock compensation) 141,620」

    The company made no additional acquisition of treasury shares during the fiscal year and disposed of 141,620 shares as restricted stock compensation.
  2. FY2026-H1Disposal of Treasury SharesAnnual report

    「Treasury shares decreased by 141,620 as a result of the disposal of treasury shares as restricted stock compensation carried out on 1 October 2025.」

    The company disposed of 141,620 treasury shares as restricted stock compensation, bringing the balance of treasury shares to 557,856.
  3. FY2025Disposal of Treasury SharesAnnual report

    「Treasury shares acquired during the fiscal year — — Other (disposal of treasury shares as restricted stock compensation) 117,690」

    The company made no additional acquisition of treasury shares during the fiscal year and disposed of 117,690 shares as restricted stock compensation.
  4. FY2024AdvancedAnnual report

    「Treasury shares acquired during the fiscal year 496,000 340,256,000」

    Based on the resolution of 11 January 2024, the company acquired 496,000 shares for ¥340 million. The unexercised portion of the acquisition limit of 1,416,800 shares was also disclosed.
  5. FY2024-Q3AdvancedAnnual report

    「In addition, based on a resolution of the Board of Directors held on 11 January 2024, the company acquired 496,000 treasury shares. As a result of this acquisition and other factors, treasury shares increased by ¥340 million during the nine-month cumulative consolidated period, to ¥550 million.」

    Under the treasury share acquisition policy, the company acquired 496,000 shares, bringing the balance of treasury shares to ¥550 million. Treasury shares totaled 817,166 at the end of the third quarter accounting period, representing 6.8% of total shares issued.
  6. FY2022AdvancedAnnual report

    「Treasury shares acquired during the fiscal year 3,300 2,563,900」

    Under the treasury share acquisition policy, the company acquired 3,300 shares for approximately ¥2.6 million during the fiscal year, bringing treasury shares held to 321,100.
  7. FY2022-Q2AdvancedAnnual report

    「Cash outflows for the acquisition of treasury shares △ 2」

    The company recorded ¥2 million in cash outflows for the acquisition of treasury shares and continued its treasury share acquisitions.
  8. FY2021AdvancedAnnual report

    「Treasury shares acquired during the fiscal year 35,000 27,184,200」

    Under the treasury share acquisition policy, the company acquired 35,000 shares for ¥27 million during the fiscal year, bringing treasury shares held at the end of the fiscal year to 317,800.
  9. FY2021-Q3RestatedAnnual report

    「Net assets stood at ¥5,935 million, down ¥11 million from ¥5,946 million at the end of the previous consolidated fiscal year. The main factors were an increase in share capital and capital surplus resulting from the issuance of new shares as restricted stock compensation, offset by decreases in retained earnings due to dividend payments and in treasury shares due to the acquisition of treasury shares.」

    The decrease in shareholders' equity due to the acquisition of treasury shares continues to be disclosed.
  10. FY2021-Q2AdvancedAnnual report

    「Cash outflows for the acquisition of treasury shares △ 8」

    The company recorded ¥8 million in cash outflows for the acquisition of treasury shares and continued acquisitions under its treasury share acquisition policy.
  11. FY2020AdvancedAnnual report

    「Treasury shares acquired during the fiscal year 269,500 172,083,300」

    Under the treasury share acquisition policy, the company acquired 269,500 shares for ¥172 million during the fiscal year. Progress against the acquisition limit of 321,100 shares was disclosed.
  12. FY2020-Q2AdvancedAnnual report

    「Cash outflows for the acquisition of treasury shares 51」

    The company recorded ¥51 million in cash outflows for the acquisition of treasury shares and held 79,700 treasury shares. Progress under the treasury share acquisition policy was disclosed.
  13. FY2020-Q1First statedAnnual report

    「Reasons for acquiring treasury shares To limit dilution and implement flexible capital management, among other purposes」

    On 11 October 2019, the company resolved to acquire treasury shares from 15 October 2019 to 9 October 2020, subject to a maximum of 321,100 shares and a maximum total acquisition cost of ¥210 million.
Moved together

"Expanding Scale and Store Network through M&A and New Store Openings" moved the same way as this thread, in the same document, in 8 of its 13 moves.

864333★123456
  1. ★This thread
  2. 1Expanding Scale and Store Network through M&A and New Store Openings8×
  3. 2Reliance on Borrowings and Risks Related to Interest Rates and Financial Covenants6×
  4. 3Unprofitable Stores and the Risk of Impairment of Fixed Assets4×
  5. 4Issuance of Stock Acquisition Rights as Stock-Based Compensation for Directors3×
  6. 5Strengthening Community Healthcare through Home Healthcare and Institutional Dispensing3×
  7. 6Subsidiary Reorganization and More Efficient Store Operations3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Pharmarise Holdings's next results are scheduled for 2026-09-17. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Containing Dilution and Flexible Capital Policy Through Share Repurchases | Pharmarise Holdings Corporation (2796) | Komori